"While the $16 EPS floor was lower than expected, it does give investors/analysts a base to model off of, and potentially sets up UNH to return to the 'beat and raise' cadence that its investors had become accustomed to," said James Harlow, senior vice president at Novare Capital Management.

While UnitedHealth remained profitable, its operating earnings for the three months fell sharply to $5.2 billion from $7.9 billion in the same period of 2024. Revenues, however, increased to $111.6 billion for the three months of 2025, compared with $98.9 billion for the same period of 2024.